SCHEMBL28219213

SCHEMBL28219213

CCC(=O)Oc1ccc(CNc2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 3/20 0.58
ELANE P08246 1/20 0.56
PPARG P37231 2/20 0.53
PPARA Q07869 2/20 0.53
RAB9A P51151 4/20 0.53
HTT P42858 2/20 0.53
LMNA P02545 1/20 0.53
FFAR1 O14842 3/20 0.53
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
FFAR4 Q5NUL3 1/20 0.51
MAPT P10636 2/20 0.51
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
ESR1 P03372 1/20 0.49
RECQL P46063 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NPC1 O15118 2/20 0.48
TP53 P04637 1/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11480519 0.94 HTT (0.60) HIF1AELANEPPARGPPARARAB9A
SCHEMBL11468430 0.85 CACNA1B (0.51) HIF1APPARARAB9AHTTLMNA
SCHEMBL2305825 0.82 FFAR1 (0.68) HIF1AFFAR1FFAR4
SCHEMBL9479518 0.81 MAPT (0.67) HIF1AELANERAB9AHTTLMNA
SCHEMBL11464615 0.79 FFAR1 (0.56) HIF1ARAB9AHTTLMNAFFAR1
N-Benzylaniline SCHEMBL11480512 0.79 FFAR1 (0.64) HIF1AHTTFFAR1KMT2AMEN1
SCHEMBL9799566 0.78 ELANE (0.72) HIF1AELANERAB9AHTTLMNA
Benzene SCHEMBL28089483 0.78 ELANE (0.72) HIF1AELANERAB9AHTTLMNA
SCHEMBL45119 0.78 ELANE (0.72) HIF1AELANERAB9AHTTLMNA
Dimethylamine SCHEMBL29129762 0.77 ELANE (0.66) HIF1AELANERAB9AHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108137518-A As 6 inhibitor of histone deacetylase 1,3,4- oxadiazole derivatives compound and include its pharmaceutical composition 株式会社钟根堂 2018-06-08 CN disclosed